Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: A systematic review and meta-analysis

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Yang, Baojuan ^a   Zhu, Lin ^a   Cheng, Haiyan ^a   Li, Qi ^a   Zhang, Yunyan ^a   Zhao, Yashuang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

3D CRT; DVH; Gynecologic malignancies; IMRT; Meta analysis

Indexed keywords

ARTICLE; BLADDER; BLOOD TOXICITY; BONE MARROW; CALCULATION; CANCER RADIOTHERAPY; CLINICAL EVALUATION; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; DOSE RESPONSE; DOSIMETRY; ENDOMETRIUM CANCER; GASTROINTESTINAL TOXICITY; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; META ANALYSIS; PATIENT SAFETY; PUBLICATION; PUBLISHING; QUANTITATIVE GENETICS; RADIATION DOSE; RECTUM; REFERENCE DATABASE; SMALL INTESTINE; SYSTEMATIC REVIEW; THREE DIMENSIONAL IMAGING; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; ORGANS AT RISK; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84869870347     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-197     Document Type: Article

References (48)

1. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1144-1153. 10.1056/NEJM199904153401502, 10202165.
2. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KA, Lutgens LC, Van Den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000, 355:1404-1411. 10.1016/S0140-6736(00)02139-5, 10791524.
3. Papp Z, Csapo Z, Mayer A, Hupuczi P. [Wertheim-operation: 5-year survival of 501 consecutive patients with cervical cancer]. Orv Hetil 2006, 147:537-545.
4. Yeoh E. Radiotherapy: long-term effects on gastrointestinal function. Curr Opin Support Palliat Care 2008, 2:40-44. 10.1097/SPC.0b013e3282f4451f, 18685393.
5. Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:1297-1308. 10.1016/j.ijrobp.2004.12.052, 16029785.
6. Gerstner N, Wachter S, Knocke TH, Fellner C, Wambersie A, Potter R. The benefit of Beam's eye view based 3D treatment planning for cervical cancer. Radiother Oncol 1999, 51:71-78. 10.1016/S0167-8140(99)00038-9, 10386719.
7. Barillot I. [Cervix carcinomas: place of intensity-modulated radiotherapy]. Cancer Radiother 2009, 13:507-510. 10.1016/j.canrad.2009.05.015, 19695927.
8. Purdy JA. Intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 1996, 35:845-846. 10.1016/0360-3016(96)00223-4, 8690655.
9. Saw CB, Ayyangar KM, Enke CA. MIMiC-based IMRT- part I. Med Dosim 2001, 26:1.
10. Saw CB, Ayyangar KM, Enke CA. MLC-based IMRT-Part II. Med Dosim 2001, 26:111-112. 10.1016/S0958-3947(01)00065-6, 11444512.
11. Bucci MK, Bevan A, Roach M. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 2005, 55:117-134. 10.3322/canjclin.55.2.117, 15761080.
12. Miles EA, Clark CH, Urbano MT, Bidmead M, Dearnaley DP, Harrington KJ, A'Hern R, Nutting CM. The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiother Oncol 2005, 77:241-246. 10.1016/j.radonc.2005.10.011, 16298002.
13. Woo SY, Sanders M, Grant W, Butler EB. Does the "peacock" have anything to do with radiotherapy?. Int J Radiat Oncol Biol Phys 1994, 29:213-214. 10.1016/0360-3016(94)90250-X, 8175435.
14. Whitton A, Warde P, Sharpe M, Oliver TK, Bak K, Leszczynski K, Etheridge S, Fleming K, Gutierrez E, Favell L, Green E. Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. Clin Oncol (R Coll Radiol) 2009, 21:192-203.
15. Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Padhani AR, Webb S, Dearnaley DP. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2000, 48:649-656. 10.1016/S0360-3016(00)00653-2, 11020560.
16. Intensity-modulated radiotherapy current status and issues of interest. Int J Radiat Oncol Biol Phys 2001, 51:880-914. Intensity-modulated radiotherapy.
17. Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001, 51:261-266.
18. Georg P, Georg D, Hillbrand M, Kirisits C, Potter R. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol 2006, 80:19-26. 10.1016/j.radonc.2006.04.014, 16766068.
19. Esik O, Bortfeld T, Bendl R, Nemeth G, Schlegel W. Inverse radiotherapy planning for a concave-convex PTV in cervical and upper mediastinal regions. Simulation of radiotherapy using an Alderson-RANDO phantom. Planning target volume. Strahlenther Onkol 1997, 173:193-200. 10.1007/BF03039288, 9111607.
20. Meeks SL, Buatti JM, Bova FJ, Friedman WA, Mendenhall WM, Zlotecki RA. Potential clinical efficacy of intensity-modulated conformal therapy. Int J Radiat Oncol Biol Phys 1998, 40:483-495. 10.1016/S0360-3016(97)00819-5, 9457839.
21. Hong L, Hunt M, Chui C, Spirou S, Forster K, Lee H, Yahalom J, Kutcher GJ, McCormick B. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 1999, 44:1155-1164. 10.1016/S0360-3016(99)00132-7, 10421550.
22. Saarilahti K, Kouri M, Collan J, Hamalainen T, Atula T, Joensuu H, Tenhunen M. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 2005, 74:251-258. 10.1016/j.radonc.2004.11.004, 15763305.
23. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2007, 68:1053-1058. 10.1016/j.ijrobp.2007.01.043, 17398023.
24. Sirak I, Kasaova L, Petera J, Vosmik M, Zoul Z. Intensity modulated radiation therapy technique in the treatment of gynecologic malignancies. Ceska Gynekol 2010, 75:177-181.
25. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 52:1330-1337. 10.1016/S0360-3016(01)02785-7, 11955746.
26. Heron DE, Gerszten K, Selvaraj RN, King GC, Sonnik D, Gallion H, Comerci J, Edwards RP, Wu A, Andrade RS, Kalnicki S. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms small star, filled. Gynecol Oncol 2003, 91:39-45. 10.1016/S0090-8258(03)00461-X, 14529660.
27. Ahmed RS, Kim RY, Duan J, Meleth S, De Los Santos JF, Fiveash JB. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys 2004, 60:505-512. 10.1016/j.ijrobp.2004.03.035, 15380585.
28. Salama JK, Roeske JC, Mehta N, Mundt AJ. Intensity-modulated radiation therapy in gynecologic malignancies. Curr Treat Options Oncol 2004, 5:97-108. 10.1007/s11864-004-0042-2, 14990204.
29. D'Souza WD, Ahamad AA, Iyer RB, Salehpour MR, Jhingran A, Eifel PJ. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 2005, 61:1062-1070. 10.1016/j.ijrobp.2004.07.721, 15752885.
30. Mell LK, Tiryaki H, Ahn KH, Mundt AJ, Roeske JC, Aydogan B. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:1504-1510. 10.1016/j.ijrobp.2008.04.046, 18640499.
31. Igdem S, Ercan T, Alco G, Zengin F, Ozgules R, Geceer G, Okkan S, Ober A, Turkan S. Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignancies. Eur J Gynaecol Oncol 2009, 30:547-551.
32. http://www.nccn.org/international/international_adaptations.asp.
33. Koh WJ. Controversies in the radiotherapeutic management of cervical cancer. J Clin Oncol 2003, 21:218s-223s. 10.1200/JCO.2003.01.224, 12743138.
34. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101. 10.2307/2533446, 7786990.
35. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634. 10.1136/bmj.315.7109.629, 2127453, 9310563.
36. Chen MF, Tseng CJ, Tseng CC, Kuo YC, Yu CY, Chen WC. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1438-1444. 10.1016/j.ijrobp.2006.11.005, 17394944.
37. Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000, 48:1613-1621. 10.1016/S0360-3016(00)00771-9, 11121668.
38. Lujan AE, Mundt AJ, Yamada SD, Rotmensch J, Roeske JC. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:516-521. 10.1016/S0360-3016(03)00521-2, 12957265.
39. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56:1354-1360. 10.1016/S0360-3016(03)00325-0, 12873680.
40. Brixey CJ, Roeske JC, Lujan AE, Yamada SD, Rotmensch J, Mundt AJ. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 54:1388-1396. 10.1016/S0360-3016(02)03801-4, 12459361.
41. Mell LK, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, Hurteau JA, Collins YC, Lengyel E, Mundt AJ. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2006, 66:1356-1365. 10.1016/j.ijrobp.2006.03.018, 16757127.
42. Beriwal S, Gan GN, Heron DE, Selvaraj RN, Kim H, Lalonde R, Kelley JL, Edwards RP. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2007, 68:166-171. 10.1016/j.ijrobp.2006.12.023, 17321070.
43. Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2011, 80(5):1436-1445. 10.1016/j.ijrobp.2010.04.041, 20708346.
44. Salama JK, Mundt AJ, Roeske J, Mehta N. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006, 65:1170-1176. 10.1016/j.ijrobp.2006.02.041, 16730136.
45. Georg D, Georg P, Hillbrand M, Potter R, Mock U. Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques. Strahlenther Onkol 2008, 184:586-591. 10.1007/s00066-008-1872-9, 19016017.
46. Mundt AJ, Roeske JC, Lujan AE, Yamada SD, Waggoner SE, Fleming G, Rotmensch J. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 2001, 82:456-463. 10.1006/gyno.2001.6250, 11520140.
47. Roeske JC, Bonta D, Mell LK, Lujan AE, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol 2003, 69:201-207. 10.1016/j.radonc.2003.05.001, 14643959.
48. Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Cervical Cancer Patients Treated with Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011, 79(3):800-807. 10.1016/j.ijrobp.2009.11.010, 2907446, 20400238.